Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway

Citation
L. Ulloa et al., Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway, NATURE, 397(6721), 1999, pp. 710-713
Citations number
30
Categorie Soggetti
Multidisciplinary,Multidisciplinary,Multidisciplinary
Journal title
NATURE
ISSN journal
00280836 → ACNP
Volume
397
Issue
6721
Year of publication
1999
Pages
710 - 713
Database
ISI
SICI code
0028-0836(19990225)397:6721<710:IOTGFS>2.0.ZU;2-O
Abstract
Transforming growth factor-beta (TGF-beta) and interferon-gamma (IFN-gamma) have opposite effects on diverse cellular functions(1-5), but the basis fo r this antagonism is not known(6). TGF-beta signals through a receptor seri ne kinase that phosphorylates and activates the transcription factors Smads 2 and 3 (refs 7, 8), whereas the IFN-gamma receptor and its associated pro tein tyrosine kinase Jak1 mediate phosphorylation and activation of the tra nscription factor Stat1 (refs 6, 9, 10). Here we present a basis for the in tegration of TGF-beta and IFN-gamma signals. IFN-gamma inhibits the TGF bet a-induced phosphorylation of Smad3 and its attendant events, namely, the as sociation of Smad3 with Smad4, the accumulation of Smad3 in the nucleus, an d the activation of TGF beta-responsive genes. Acting through Jak1 and Stat 1, IFN-gamma induces the expression of Smad7, an antagonistic SMAD(11,12), which prevents the interaction of Smad3 with the TGF-beta receptor. The res ults indicate a mechanism of transmodulation between the STAT and SMAD sign al-transduction pathways.